Efficacy and Safety Study of ME1111 in Patients With Onychomycosis

NCT02022215 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

304

Enrollment

INDUSTRY

Sponsor class

Conditions

Onychomycosis

Interventions

DRUG: ME1111 Solution, Low strength
DRUG: ME1111 Solution, High strength
DRUG: Matching Vehicle Solution

Sponsor

Meiji Seika Pharma Co., Ltd.